Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
46.55
+3.84 (8.99%)
Nov 6, 2026, 4:00 PM EST - Market closed
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $133.79 million as of November 6, 2026. It is the 22,945th most valuable company in the world and the 3,858th biggest in the United States. Its market cap has increased by 97.85% in one year.
Market Cap
133.79M
Enterprise Value
45.16M
1-Year Change
97.85%
Global Rank
Country Rank
#3,858 United States
Category
ChartMarket Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $133.79M, a decrease of -64.65%. That is a compound annual growth rate of -15.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 133.79M | 43.48% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 143.01M |
| Atrium Therapeutics | 142.66M |
| Compass Therapeutics | 136.65M |
| Cue Biopharma | 136.06M |
| Protara Therapeutics | 135.92M |
| Veraxa Biotech AG | 134.34M |
| Adagene | 134.29M |
| Jyong Biotech | 133.62M |